← Back to Search

Cannabinoid

Medical Marijuana Arm for Anxiety (MMNE Trial)

N/A
Waitlist Available
Led By Jodi M Gilman, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks, 4 weeks, and 12 weeks
Awards & highlights

MMNE Trial Summary

This trial will study whether medical marijuana helps patients with specific health outcomes, or causes new problems, compared to a control group.

Eligible Conditions
  • Anxiety
  • Depression
  • Pain
  • Insomnia

MMNE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks, 4 weeks, and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks, 4 weeks, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean Difference in Anxiety Subscale Scores From the HADS Averaged Over 2, 4, and 12 Weeks
Mean Difference in Depression Subscale Scores From the HADS Averaged Over 2, 4, and 12 Weeks
Mean Difference in Number of Cannabis Use Disorder Symptoms Averaged Over 2, 4, and 12 Weeks
+2 more
Secondary outcome measures
Mean Difference in Attention Switching Task: Congruency Cost Scores on the CANTAB Averaged Over 4 and 12 Weeks
Mean Difference in Attention Switching Task: Switching Cost Scores on the CANTAB Averaged Over 4 and 12 Weeks
Mean Difference in Mental Health Scores on the SF-12 Averaged Over 2, 4, and 12 Weeks
+6 more

MMNE Trial Design

2Treatment groups
Active Control
Group I: Waitlist Control ArmActive Control1 Intervention
This group agrees to wait 3 months before using medical marijuana.
Group II: Medical Marijuana ArmActive Control1 Intervention
This group can begin using medical marijuana immediately.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,932 Previous Clinical Trials
13,198,226 Total Patients Enrolled
25 Trials studying Anxiety
3,262 Patients Enrolled for Anxiety
Jodi M Gilman, PhDPrincipal InvestigatorAssistant Professor
1 Previous Clinical Trials
316 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Effect of Medical Marijuana on Neurocognition and Escalation of Use
Jodi Gilman 2017. "Effect of Medical Marijuana on Neurocognition and Escalation of Use". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03224468.
~35 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top